Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Sep. 27, 2020	Sep. 29, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 823,451	$ 465,789
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	72,912	64,664
Deferred income taxes	(1,850)	(2,992)
Equity-based compensation expense	55,988	42,905
Amortization of note discounts and issuance costs	1,422	1,675
Other, net	2,917	4,026
Changes in operating assets and liabilities	(312,329)	(112,020)
Net cash provided by operating activities	642,511	464,047
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets	(62,806)	(39,256)
Purchases of available-for-sale securities	(1,750,188)	(147,632)
Maturities of available-for-sales securities	597,252	600,347
Sales of available-for-sale securities	415,862	337,763
Other, net	(1,786)	(540)
Net cash (used for) provided by investing activities	(801,666)	750,682
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt	(19,173)	(28,965)
Treasury stock purchases	(448,581)	(78,132)
Dividends paid	(167,129)	(158,868)
Proceeds from issuance of common stock	5,538	3,869
Other, net	(2,140)	0
Net cash used for financing activities	(631,485)	(262,096)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	4,082	(4,193)
Net (decrease) increase in cash, cash equivalents, and restricted cash	(786,558)	948,440
Cash, cash equivalents, and restricted cash at beginning of period	5,169,083	3,913,396
Cash, cash equivalents, and restricted cash at end of period	4,382,525	4,861,836
Schedule of non-cash transactions:
Accrued payables for stock repurchases	18,599	13
Accrued payables for capital expenditures	37,733	30,333
Transfers of inventory to property and equipment, net	29,019	13,997
Reconciliation of cash, cash equivalents, and restricted cash
Total cash, cash equivalents, and restricted cash	$ 4,382,525	$ 4,861,836